Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery

Changyi Chen, Stephen R. Hanson, Larry K. Keefer, Joseph E. Saavedra, Keith M. Davies, Thomas C. Hutsell, John D. Hughes, David N. Ku, Alan B. Lumsden

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

To evaluate the direct effect of nitric oxide (NO) on vascular smooth muscle cell (SMC) proliferation in vivo, we used an expanded polytetrafluoroethylene (ePTFE)-based local infusion device to deliver an NO donor, proline/NO (PROLI/NO), to the luminal boundary layer of endarterectomized artery and the distal anastomosis of the graft in a canine model. Once delivered to the blood, PROLI/NO releases NO by a mechanism involving pH-dependent decomposition. Six dogs underwent bilateral femoral artery endarterectomies. ePTFE infusion devices, blindly primed with PROLI/NO to one artery or proline to the contralateral vessel, were anastomosed proximal to the injured segments so that each animal served as its own control. PROLI/NO or proline was continuously delivered for 7 days from an osmotic reservoir, through the wall of the graft infusion device. Euthanasia was carried out at 7 days, and the processed specimens were blindly analyzed for SMC proliferation at both graft anastomoses and endarterectomized segments by a bromodeoxyuridine index assay. All dogs survived with no clinical side effects. In comparing the treated and control vessels, NO released from PROLI/NO significantly reduced SMC proliferation by 43% (13.24 ± 1.24% versus 23.24 ± 1.01%, P = 0.004) at the distal anastomoses and by 68% (10.58 ± 1.63% versus 25.17 ± 3.39%, P = 0.007) at endarterectomized segments. However, there was no significant difference in blood flow measurements between treated and control arteries (56.25 ± 6.50 ml/min versus 46.50 ± 3.20 ml/min, P = 0.094). These data demonstrate that local boundary layer infusion of NO released from PROLI/NO significantly reduces SMC proliferation in injured arteries with no effect on regional blood flow. This study suggests a new strategy to inhibit early SMC proliferation in injured arteries and probably to control intimal hyperplastic lesion formation in the manipulated vessels.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalJournal of Surgical Research
Volume67
Issue number1
DOIs
StatePublished - Jan 1997

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery'. Together they form a unique fingerprint.

Cite this